NXNNEXSEN LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 29 July 2026, 18:33 | Quarterly Report - Q4 FY26 | Quarterly Reports | MS | 19004, 19009 | |
| 23 July 2026, 19:07 | Launch of Hong Kong facility & pipeline expansion | Company Update | — | 11001 | |
| 30 June 2026, 18:43 | Global Healthcare CEO Joins Nexsen Advisory Board | Company Administration | — | 12008 | |
| 25 June 2026, 18:36 | $1.5m non-dilutive ARC funding for manufacturing | Capital Raising | MS | 03022, 11001 | |
| 16 May 2026, 03:11 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 13 May 2026, 18:55 | Nexsen secures first hospital partner in Asia | Company Update | MS | 11001 | |
| 4 May 2026, 18:17 | Nexsen and Universiti Malaya launch joint facility | Company Update | MS | 11001 | |
| 28 Apr 2026, 19:35 | Quarterly Report - Q3 FY26 | Quarterly Reports | MS | 19003, 19008 | |
| 7 Apr 2026, 18:25 | QMS milestone achieved | Company Update | MS | 11001 | |
| 31 Mar 2026, 19:31 | HK$6 million grant awarded to advance Asia-Pacific execution | Periodic Reports | MS | 03014 | |
| 26 Mar 2026, 19:17 | Nexsen accelerates global rollout for StrepSure | Company Update | MS | 11001 | |
| 23 Mar 2026, 19:26 | FDA feedback derisks US approval pathway for StrepSure | Company Update | MS | 11001 | |
| 27 Feb 2026, 20:11 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 27 Feb 2026, 20:03 | Change in substantial holding - Nexsen | Substantial Holders | — | 02002 | |
| 25 Feb 2026, 19:33 | Nexsen highlights GBS strategy at ISSAD 2026 | Company Administration | — | 12008 | |
| 25 Feb 2026, 19:20 | Application for quotation of securities - NXN | Other | — | 06020 | |
| 6 Feb 2026, 19:48 | Change in substantial holding - Nexsen | Substantial Holders | — | 02002 | |
| 6 Feb 2026, 19:20 | Application for quotation of securities - NXN | Other | — | 06020 | |
| 30 Jan 2026, 06:29 | Quarterly Report - Q2 FY26 | Quarterly Reports | MS | 19002, 19007 | |
| 27 Jan 2026, 20:13 | $500k govt grant expands GBS project to neonates | Periodic Reports | MS | 03014 | |
| 24 Jan 2026, 01:42 | Notice under ASX Listing Rule 3.10A | Securities Administration | — | 06009 | |
| 6 Jan 2026, 20:18 | Business Update - FDA engagement underway & key appointment | Company Update | — | 11001, 12008 | |
| 8 Dec 2025, 19:49 | Investor Presentation | Presentations | MS | 03026 | |
| 6 Dec 2025, 05:16 | Initial Directors Interest Notice - Kumta | Director Interests | — | 02008 | |
| 3 Dec 2025, 20:14 | Nexsen Appoints Global Clinical Leader to the Board | Company Update | MS | 11001, 12001 | |
| 22 Nov 2025, 03:24 | Results of AGM | Meetings & Governance | — | 08003 | |
| 21 Nov 2025, 20:34 | Chairman's Address to AGM | Letters & Addresses | — | 15002 | |
| 6 Nov 2025, 20:17 | Nexsen accelerates US diagnostics market entry | Company Update | — | 11001 | |
| 31 Oct 2025, 22:24 | Quarterly Report - Q1 FY26 | Quarterly Reports | MS | 19001, 19006 | |
| 24 Oct 2025, 19:42 | Notice of Annual General Meeting | Meetings & Governance | — | 08001, 08004 | |
| 21 Oct 2025, 20:01 | Nexsen launches clinical trial for GBS Rapid Sensor | Company Update | MS | 11001 | |
| 16 Oct 2025, 03:33 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 14 Oct 2025, 22:52 | Nexsen sucessfully lists on ASX | Company Administration | — | 12008 | |
| 14 Oct 2025, 22:52 | Directors Interest Notices | Director Interests | — | 02008 | |
| 14 Oct 2025, 22:51 | Becoming a substantial holder - Muzzin | Substantial Holders | — | 02001 | |
| 14 Oct 2025, 22:51 | Becoming a substantial holder - Nexsen | Letters & Addresses | — | 02001, 16002 | |
| 11 Oct 2025, 02:22 | Pre Quotation Disclosures | Company Administration | — | 06009, 09008, 12008 | |
| 11 Oct 2025, 02:21 | Top 20 Holders | Company Administration | — | 06009, 09008 | |
| 11 Oct 2025, 02:18 | Distribution Schedule | Company Administration | — | 06009, 09008 | |
| 11 Oct 2025, 02:17 | Securities Trading Policy | Company Administration | — | 09008, 14013 | |
| 11 Oct 2025, 02:16 | Corporate Governance Statement | Company Administration | — | 03024, 09008 | |
| 11 Oct 2025, 02:14 | Employee Incentive Securities Plan | Company Administration | — | 09008, 12008 | |
| 11 Oct 2025, 02:12 | Annual Report - 30 June 2025 | Periodic Reports | — | 03014, 09008 | |
| 11 Oct 2025, 02:11 | Annual Report - 30 June 2024 | Periodic Reports | — | 03014, 09008 | |
| 11 Oct 2025, 02:11 | Constitution | Company Administration | — | 09008, 12012 | |
| 11 Oct 2025, 02:10 | Prospectus | Company Administration | — | 06010, 09008 | |
| 11 Oct 2025, 02:09 | Information Form and Checklist | Company Administration | — | 09008, 12008 | |
| 11 Oct 2025, 02:08 | Appendix 1A | Company Administration | — | 06009, 09008 | |
| 11 Oct 2025, 02:08 | ASX Market Announcement - Admission and Quotation | Company Administration | — | 09008, 09009 |
1–49 of 49
1 / 1